Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Notice of Redemption and Delisting

23rd Jun 2025 16:59

RNS Number : 0452O
Mortimer BTL 2022-1 PLC
23 June 2025
 

RNS Notification

MORTIMER BTL 2022-1 PLC

(the "Issuer")

 

NOTICE OF REDEMPTION AND DELISTING

to the holders of the following notes and certificates

 of the Issuer presently outstanding

£234,900,000 Class A Notes due March 2054

(ISIN: XS2463569983, Common Code: 246356998)

£16,200,000 Class B Notes due March 2054

(ISIN: XS2463702493, Common Code: 246370249)

£9,450,000Class C Notes due March 2054

(ISIN: XS2463702816, Common Code: 246370281)

£4,050,000 Class D Notes due March 2054

(ISIN: XS2463703384, Common Code: 246370338)

£5,400,000Class E Notes due March 2054

(ISIN: XS2463703467, Common Code: 246370346)

£4,725,000 Class X Notes due March 2054

(ISIN: XS2463703541, Common Code: 246370354)

(the "Noteholders" and the "Notes", respectively)

Registered Global Certificates

(ISIN: XS2470631610, Common Code: 247063161)

 (the "Certificateholders" and the "Certificates", respectively)

 

The Notes are admitted to the official list of the Financial Conduct Authority and to trading on the regulated market of the London Stock Exchange.

 

Capitalised terms used, but not defined herein, shall have the meaning given thereto in the Prospectus dated 6 May 2022.

 

NOTICE IS HEREBY GIVEN that the Notes have been redeemed in full and the Certificates cancelled by the Issuer on 23 June 2025. The Issuer hereby announces that they have requested the cancellation of the listing of the Notes on the Official List maintained by the Financial Conduct Authority and the Issuer's admission to trading on the London Stock Exchange plc of the Notes, effective immediately.

 

This notice is given by:

 

MORTIMER BTL 2022-1 PLC

 

Dated 23 June 2025

Disclaimer - Intended Addressees

Please note that the information contained in this announcement and the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom this announcement and the Prospectus is not addressed. Prior to relying on the information contained in this announcement you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.

In particular, this announcement and the Prospectus do not constitute an offer or invitation to subscribe for, or purchase, securities in the United States or in any other jurisdiction where such an offer or invitation would be unlawful. This announcement and the Prospectus are not for distribution in the United States or to U.S. persons (as defined below) other than to qualified institutional buyers within the meaning of and in reliance on Rule 144A of the U.S. Securities Act of 1933, as amended (the Securities Act). The securities described herein have not been, and will not be, registered under the Securities Act or under any relevant securities laws of any state of the United States of America and are subject to U.S. tax law requirements. The securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons or to persons within the United States of America (as such terms are defined in Regulation S under the Securities Act) except pursuant to registration or an exemption from the registration requirements of the Securities Act. There will be no public offering of the securities in the United States. For a description of the restrictions on offers and sales of the securities described herein, please refer to the Prospectus.

Your right to access this service is conditional upon complying with the above requirement.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFEERAIVFIE

Related Shares:

Mort.bt 22-1.54
FTSE 100 Latest
Value8,962.73
Change-12.93